Phathom Pharmaceuticals (PHAT) Receivables - Net (2023 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Receivables - Net of $97.4 million for Q2 2026, up 90.07% year-over-year from $51.3 million in Q2 2025, and up 20.69% quarter-over-quarter from $80.7 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Receivables - Net (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Receivables - Net for 4 consecutive years, with $97.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Receivables - Net rose 90.07% year-over-year to $97.4 million; the TTM figure through Jun 2026 stood at $97.4 million (up 90.07% YoY), while the FY2025 annual figure was $78.1 million, up 101.38% from the prior year.
- Receivables - Net grew to $97.4 million in Q2 2026 per PHAT's latest filing, from $80.7 million in the prior quarter.
- Across five years, Receivables - Net topped out at $97.4 million in Q2 2026 and bottomed at $1.3 million in Q4 2023.
- Historically, Receivables - Net has averaged $43.1 million across 4 years, with a median of $38.8 million in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Net jumped 2875.23% — and 2026, when it surged 90.07%.
- Phathom Pharmaceuticals' Receivables - Net stood at $1.3 million in 2023, then surged by 2875.23% to $38.8 million in 2024, then soared by 96.17% to $76.1 million in 2025, then rose by 28.0% to $97.4 million in 2026.
- Business Quant data shows PHAT's Receivables - Net at $97.4 million in Q2 2026, $80.7 million in Q1 2026, and $76.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 97.42 Mn |
| Jun 30, 2026 | 97.42 Mn |
| Mar 31, 2026 | 80.72 Mn |
| Mar 31, 2026 | 80.72 Mn |
| Dec 31, 2025 | 78.13 Mn |
| Dec 31, 2025 | 78.13 Mn |
| Sep 30, 2025 | 55.79 Mn |
| Sep 30, 2025 | 55.79 Mn |
| Jun 30, 2025 | 51.26 Mn |
| Jun 30, 2025 | 51.26 Mn |
| Mar 31, 2025 | 36.36 Mn |
| Mar 31, 2025 | 36.36 Mn |
| Dec 31, 2024 | 38.80 Mn |
| Dec 31, 2024 | 38.80 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Sep 30, 2024 | 21.05 Mn |
| Jun 30, 2024 | 10.88 Mn |
| Jun 30, 2024 | 10.88 Mn |
| Mar 31, 2024 | 3.88 Mn |
| Mar 31, 2024 | 3.88 Mn |